MPM BioImpact’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
Other funds holding NGNE
BBA
MPM BioImpact's NGNE Position: Q3 2026 in Review
MPM BioImpact opened a new position in Neurogene (NGNE) in Q3 2026: 771,839 shares worth $21.5M. The stake represents 1.59% of the portfolio and ranks #30 among its holdings.
132 funds tracked by Wall St. Rank hold NGNE as of Q3 2026.
- MPM BioImpact held 771,839 shares of Neurogene worth $21.5M as of Q3 2026.
- Neurogene was a new MPM BioImpact position in Q3 2026.
- Neurogene made up 1.59% of MPM BioImpact's portfolio in Q3 2026, its #30 holding.
- 132 funds tracked by Wall St. Rank held Neurogene as of Q3 2026.
Based on MPM BioImpact's 13F filing for Q3 2026, filed 16 Nov 2026.